CAAS Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-169,771
Closed -$10.5M 880
2020
Q4
$10.5M Buy
169,771
+144,251
+565% +$8.94M 0.1% 75
2020
Q3
$825K Buy
+25,520
New +$825K 0.02% 196